Tower Research Capital (TRC)’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $419 | Buy |
+238
| New | +$511 | ﹤0.01% | 5039 |
|
|
2025
Q4 | – | Sell |
-194
| Closed | -$549 | – | 5166 |
|
|
2025
Q3 | $549 | Buy |
+194
| New | +$614 | ﹤0.01% | 4981 |
|
|
2024
Q4 | – | Sell |
-482
| Closed | -$1.26K | – | 5701 |
|
|
2024
Q3 | $1.26K | Sell |
482
-5
| -1% | -$14 | ﹤0.01% | 5182 |
|
|
2024
Q2 | $1.71K | Sell |
487
-89
| -15% | -$453 | ﹤0.01% | 5105 |
|
|
2024
Q1 | $3.83K | Sell |
576
-198
| -26% | -$1.61K | ﹤0.01% | 4782 |
|
|
2023
Q4 | $7.74K | Buy |
774
+4
| +0.5% | +$30 | ﹤0.01% | 4586 |
|
|
2023
Q3 | $5.29K | Buy |
770
+36
| +5% | +$357 | ﹤0.01% | 4740 |
|
|
2023
Q2 | $7.98K | Sell |
734
-234
| -24% | -$2.77K | ﹤0.01% | 4494 |
|
|
2023
Q1 | $14K | Buy |
968
+759
| +363% | +$16.4K | ﹤0.01% | 3865 |
|
|
2022
Q4 | $6K | Buy |
+209
| New | +$6K | ﹤0.01% | 4685 |
|
|
2022
Q3 | – | Sell |
-346
| Closed | -$8K | – | 6067 |
|
|
2022
Q2 | $8K | Buy |
346
+182
| +111% | +$5.2K | ﹤0.01% | 4656 |
|
|
2022
Q1 | $6K | Sell |
164
-25
| -13% | -$831 | ﹤0.01% | 4853 |
|
|
2021
Q4 | $6K | Buy |
+189
| New | +$7.28K | ﹤0.01% | 5009 |
|
|
2021
Q3 | – | Sell |
-61
| Closed | -$2K | – | 5770 |
|
|
2021
Q2 | $2K | Buy |
+61
| New | +$2.07K | ﹤0.01% | 5018 |
|
|
2021
Q1 | – | Sell |
-230
| Closed | -$9K | – | 5402 |
|
|
2020
Q4 | $9K | Buy |
230
+212
| +1,178% | +$10.6K | ﹤0.01% | 4368 |
|
|
2020
Q3 | $1K | Sell |
18
-161
| -90% | -$10.4K | ﹤0.01% | 4676 |
|
|
2020
Q2 | $11K | Buy |
+179
| New | +$10K | ﹤0.01% | 3957 |
|
|
2019
Q3 | – | Sell |
-137
| Closed | -$3K | – | 4094 |
|
|
2019
Q2 | $3K | Buy |
+137
| New | +$2.63K | ﹤0.01% | 3112 |
|
|
2019
Q1 | – | Sell |
-6
| Closed | – | – | 3799 |
|
|
2018
Q4 | $0 | Buy |
+6
| New | +$135 | ﹤0.01% | 3830 |
|
|
2018
Q2 | – | Sell |
-397
| Closed | -$13K | – | 3653 |
|
|
2018
Q1 | $13K | Buy |
397
+379
| +2,106% | +$13K | ﹤0.01% | 2353 |
|
|
2017
Q4 | $1K | Buy |
+18
| New | +$480 | ﹤0.01% | 3323 |
|
|
2017
Q2 | – | Sell |
-12
| Closed | – | – | 2720 |
|
|
2017
Q1 | $0 | Buy |
+12
| New | +$227 | ﹤0.01% | 3085 |
|
|
2016
Q4 | – | Sell |
-4
| Closed | – | – | 3827 |
|
|
2016
Q3 | $0 | Buy |
+4
| New | +$88 | ﹤0.01% | 3660 |
|
Other funds holding BMRA
HF
NA
HCM
Tower Research Capital (TRC)'s BMRA Position: Q2 2026 in Review
Tower Research Capital (TRC) opened a new position in Biomerica (BMRA) in Q2 2026: 238 shares worth $419. The stake represents ﹤0.01% of the portfolio and ranks #5039 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BMRA as recently as Q3 2025.
Tower Research Capital (TRC) first reported a position in BMRA in Q3 2016 and has held it in 23 quarters since. The position peaked at $14K in Q1 2023. 20 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.
- Tower Research Capital (TRC) held 238 shares of Biomerica worth $419 as of Q2 2026.
- Biomerica was a new Tower Research Capital (TRC) position in Q2 2026.
- Biomerica made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5039 holding.
- Tower Research Capital (TRC) first reported a position in Biomerica in Q3 2016 and has held it in 23 quarters since.
- Tower Research Capital (TRC)'s Biomerica position peaked at $14K in Q1 2023.
- 20 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.